Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 11
2004 3
2005 1
2006 4
2007 4
2008 7
2009 1
2010 3
2011 4
2012 1
2013 1
2014 1
2015 4
2016 2
2017 4
2018 6
2019 1
2020 3
2021 2
2022 1
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study.
Kawabata R, Chin K, Takahari D, Hosaka H, Muto O, Shindo Y, Nagata N, Yabusaki H, Imamura H, Endo S, Kashiwada T, Nakamura M, Hihara J, Kobayashi M, Sagawa T, Saito S, Sato A, Yamada T, Okano N, Shimada K, Matsushima M, Kataoka M, Matsumoto S, Goto M, Kotaka M, Shiraishi T, Yamai H, Nagashima F, Ishizuka N, Yamaguchi K. Kawabata R, et al. Among authors: sagawa t. Gastric Cancer. 2023 Nov;26(6):1020-1029. doi: 10.1007/s10120-023-01423-z. Epub 2023 Aug 23. Gastric Cancer. 2023. PMID: 37610558 Free PMC article. Clinical Trial.
Nationwide multicenter study on adverse events associated with a patency capsule: Additional survey of appropriate use of patency capsule study.
Omori T, Ohmiya N, Watanabe K, Hirai F, Nakamura M, Kitamura K, Ozeki K, Oka S, Kawano S, Handa O, Kawai M, Ninomiya K, Sagawa T, Wakamatsu T, Araki A, Koike Y, Kato S, Hashimoto S, Mannami T, Nakaji K, Tanaka S, Matsui T; J-POP study group. Omori T, et al. Among authors: sagawa t. J Gastroenterol Hepatol. 2024 Feb;39(2):337-345. doi: 10.1111/jgh.16365. Epub 2023 Oct 16. J Gastroenterol Hepatol. 2024. PMID: 37842961
Identifying Early Predictive Markers for Immune-Related Adverse Events in Nivolumab-Treated Patients with Renal Cell Carcinoma and Gastric Cancer.
Takada S, Murooka H, Tahatsu K, Yanase M, Umehara K, Hashishita H, Toru H, Satoru M, Sagawa T, Fujikawa K, Sato H, Mino K. Takada S, et al. Among authors: sagawa t. Asian Pac J Cancer Prev. 2022 Feb 1;23(2):695-701. doi: 10.31557/APJCP.2022.23.2.695. Asian Pac J Cancer Prev. 2022. PMID: 35225483 Free PMC article.
Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08.
Masuishi T, Tsuji A, Kotaka M, Nakamura M, Kochi M, Takagane A, Shimada K, Denda T, Segawa Y, Tanioka H, Hara H, Sagawa T, Watanabe T, Takahashi T, Negoro Y, Manaka D, Fujita H, Suto T, Takeuchi M, Ichikawa W, Fujii M. Masuishi T, et al. Among authors: sagawa t. Br J Cancer. 2020 Nov;123(10):1490-1495. doi: 10.1038/s41416-020-01042-w. Epub 2020 Aug 31. Br J Cancer. 2020. PMID: 32863385 Free PMC article. Clinical Trial.
Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II study.
Ohnuma H, Sato Y, Hayasaka N, Matsuno T, Fujita C, Sato M, Osuga T, Hirakawa M, Miyanishi K, Sagawa T, Fujikawa K, Ohi M, Okagawa Y, Tsuji Y, Hirayama M, Ito T, Nobuoka T, Takemasa I, Kobune M, Kato J. Ohnuma H, et al. Among authors: sagawa t. Cancer Sci. 2018 Nov;109(11):3554-3563. doi: 10.1111/cas.13772. Epub 2018 Sep 25. Cancer Sci. 2018. PMID: 30137686 Free PMC article. Clinical Trial.
68 results